Association between alcohol consumption in healthy midlife and telomere length in older men. The Helsinki Businessmen Study

European Journal of Epidemiology

Volumn 27, Issue 10, 2012, Pages 815-822

  Strandberg, Timo E ^a,b   Strandberg, Arto ^b   Saijonmaa, Outi ^b   Tilvis, Reijo S ^b   Pitkälä, Kaisu H ^c   Fyhrquist, Frej ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Aged; Alcohol; Midlife; Telomere

Indexed keywords

CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; FITNESS; HUMAN; HUMAN CELL; LEUKOCYTE TELOMERE LENGTH; MALE; SMOKING; SOUTHERN BLOTTING; TELOMERE;

AGE FACTORS; AGED; ALCOHOL DRINKING; FINLAND; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TELOMERE SHORTENING;

EID: 84871346338     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9728-0     Document Type: Article

References (40)

1. Schutze M, Boeing H, Pischon T, et al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ. 2011;7(342): D1584. doi:10.1136/bmj.d1584.
2. Ronksley PE, Brien SE, Turner BJ, et al. Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis. BMJ. 2011;22(342):d671. doi:10.1136/bmj.d671.
3. Peters R, Peters J, Warner J, et al. Alcohol dementia and cognitive decline in the elderly: A systematic review. Age Ageing. 2008;37:505-12.
4. Lee SJ, Sudore RL, Williams BA, et al. Functional limitations, socioeconomic status, and all-cause mortality in moderate alcohol drinkers. J Am Geriatr Soc. 2009;57:955-62.
5. Lang IA, Melzer D. Moderate alcohol consumption in later life: Time for a trial? J Am Geriatr Soc. 2009;57:1110-2.
6. Blackburn EH. Structure and function of telomeres. Nature. 1991; 350:569-73.
7. Aviv A. Telomeres and human somatic fitness. J Gerontol Biol Sci Med. 2006;61:871-3.
8. Calado RT, Young NS. Telomere diseases. N Engl J Med. 2009; 361:2353-65.
9. Mather J, Jorm AF, Parslow RA, et al. Is telomere length a biomarker of aging? A review. J Gerontol Biol Sci Med. 2011; 61:871-3.
10. Fitzpatrick AL, Kronmal RA, Gardner JP, et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol. 2007;65:14-21.
11. Farzaneh-Far R, Cawthon RM, Na B, et al. Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: Data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol. 2008;28:1379-84.
12. Willeit P, Willeit J, Brandstatter A, et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Atheroscler Thromb Vasc Biol. 2010;30:1649-56.
13. Sampson MJ, Winterbone MS, Hughes JC, et al. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care. 2006;29:283-9.
14. Willeit P, Willeit J, Mayr A, et al. Telomere length and risk of incident cancer and cancer mortality. JAMA. 2010;304:69-75.
15. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005;366: 662-4.
16. Strandberg TE, Saijonmaa O, Tilvis RS, et al. Association of telomere length in older men with mortality and midlife body mass index and smoking. J Geront Med Sci. 2011;66:815-20.
17. Strandberg TE, Saijonmaa O, Tilvis RS, et al. Telomere length in old age and cholesterol across the life course. J Am Geriatr Soc. 2011;59:1979-81.
18. Fyhrquist F, Silventoinen K, Saijonmaa O, et al. Telomere length and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE study. J Hum Hypertens. 2011;25: 711-8.
19. Pavanello S, Hoxha M, Dioni L, et al. Shortened telomeres in individuals with abuse in alcohol consumption. Int J Cancer. 2011;129:983-92.
20. Miettinen TA, Huttunen JK, Naukkarinen V, et al. Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence and mortality. JAMA. 1985;254:2097-102.
21. Strandberg AY, Strandberg TE, Salomaa VV, Pitkala K, Miettinen TA. Alcohol consumption, total mortality, anf quality of life in men in old age. Am J Clin Nutr. 2004;80:1366-71.
22. Mukamal KJ, Conigrave KM, Mittleman MA, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med. 2003;348:109-18.
23. Fyhrquist F, Tiitu A, Saijonmaa O, Forsblom C, Groop P-H. on behalf of the FinnDiane Study Group. Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes. J Intern Med. 2010;267:278-86.
24. Zou Y, Sfeir A, Gryaznov SM, et al. Does a sentinel or a subset of short telomeres determine replicative senescence? Mol Biol Cell. 2004;15:3709-18.
25. Hemann MT, Strong MA, Hao LY, et al. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 2001;107:67-77.
26. Bendix L, Bendix Horn P, Birk Jensen UB, et al. The load of short telomeres, estimated by a new method, Universal STELA, correlates with number of senescent cells. Aging Cell. 2010;9: 383-97.
27. Harris SE, Deary IJ, MacIntyre A, et al. The association between telomere length, physical health, cognitive ageing, and mortality in non-demented older people. Neurosci Lett. 2006;406:260-4.
28. Hou L, Savage SA, Blaser MJ, et al. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18:3103-9.
29. Mirabello L, Huang WY, Wong JYY, et al. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell. 2009;8:405-13.
30. Di Castelnuovo A, Costanzo S, di Giuseppe R, et al. Alcohol consumption and cardiovascular risk: Mechanisms of action and epidemiologic perspectives. Future Cardiol. 2009;5:467-77.
31. Liao CT, Chen IH, Chang JT, et al. Lack of correlation of betel nut chewing, tobacco smoking, and alcohol consumption with telomerase activity and the severity of oral cancer. Chang Gung Med J. 2003;26:637-45.
32. Ornish D, Lin J, Daubenmier J, et al. Increased telomerase activity and comprehensive lifestyle changes: A pilot study. Lancet Oncol. 2008;9:1048-57.
33. Lieber CS. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Adv Pharmacol. 1997; 38:601-28.
34. Comporti M, Signorini C, Leoncini S, et al. Ethanol-induced oxidative stress: Basic knowledge. Genes Nutr. 2010;5:101-9.
35. Ludlow AT, Zimmerman JB, Witkowski S, et al. Relationships between physical activity level, telomere length, and telomerase activity. Med Sci Sports Exerc. 2008;40:1764-71.
36. Aubert G, Hills M, Lansdorp PM. Telomere length measurement-Caveats and a critical assessment of the available technologies and tools. Mutat Res. 2012;730:59-67.
37. Aviv A, Hunt SC, Lin J, Cao X, Kimura M, Blackburn E. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic Acids Res. 2011;39:e134.
38. Unryn BM, Cook LS, Riabowol KT. Paternal age is positively linked to telomere length of children. Aging Cell. 2005;4:97-101.
39. Farzaneh-Far R, Kin J, Epel ES, et al. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA. 2010;303:250-7.
40. Wilson WR, Herbert KE, Mistry Y, et al. Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. Eur Heart J. 2008; 29:2689-94.